PMID: 7542048Jan 1, 1995Paper

Helix-stabilizing compounds CC-1065 and U-71,184 bind to RNA-DNA and DNA-DNA duplexes containing modified internucleotide linkages and stabilize duplexes against thermal melting

Antisense Research and Development
D Y KimD H Swenson

Abstract

CC-1065 and U-71,184 bind and hyperstabilize DNA duplexes, but little is known about their effects on nucleic acid duplexes of different structure. A 20 mer DNA sequence (5'-TTACTTCAGTTATGAGACCA) containing a drug binding sequence (5'-AGTTA) was selected as the target sequence, and this was duplexed with complementary antisense sequences containing phosphodiester (PO), phosphorothioate (PS), and methylphosphonate (MP) bonds. The duplexes containing PO or PS bound 2 CC-1065 molecules per duplex, presumably at both the target site and at a lower affinity site (5'-AGTAA) on the antisense strand. The duplex containing MP bound only 1 CC-1065, and all duplexes bound only 1 U-71,184. Both CC-1065 and U-71,184 bound to 20 mer duplexes comprised of oligo(dA)-oligo(dT) (2.5 and 2 drugs per duplex, respectively) and poly(rA)-oligo(dT) (1 drug per 20 base pairs). CC-1065 also bound to duplexes between the PO- or PS-based antisense structures and a complementary synthetic 20 mer RNA sequence, with about 1 drug per duplex in each case. CC-1065 increased the Tm for the 20 mer DNA duplexes 17 to 29 degrees C, and the corresponding values for U-71,184 ranged from 7 to 19 degrees C. CC-1065 raised the Tm of oligo(dA)-oligo(dT) and poly(rA)-olig...Continue Reading

References

Dec 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·M Z RatajczakA M Gewirtz
Jan 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·C BoiziauJ J Toulmé
Sep 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·E RapaportP Zamecnik
Dec 1, 1991·Pharmacology & Therapeutics·C A SteinL Yakubov
Jun 11, 1991·Nucleic Acids Research·L Kibler-HerzogW D Wilson
Jan 1, 1991·Antisense Research and Development·L WhitesellL M Neckers
May 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·S L LokeL M Neckers
Jul 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·R Y Walder, J A Walder
Mar 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·M L KopkaR E Dickerson
May 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·C C SmithP O Ts'o
Jan 1, 1988·Chemico-biological Interactions·D H SwensonW C Krueger
Feb 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·E L WickstromE Wickstrom
Sep 1, 1986·Journal of Biochemical and Biophysical Methods·E Wickstrom
Aug 1, 1985·Biopolymers·W C KruegerD H Swenson
Sep 1, 1966·Journal of Molecular Biology·M M Warshaw, I Tinoco
Jun 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·U AsselineC Hélène
Sep 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·Z Dominski, R Kole

❮ Previous
Next ❯

Citations

Apr 23, 2008·Current Protocols in Nucleic Acid Chemistry·Igor KutyavinMichael W Reed
Jan 1, 1996·Antisense & Nucleic Acid Drug Development·A S LevinaP C Zamecnik

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.